Atomistry » Fluorine » PDB 7mmi-7n13 » 7mx7
Atomistry »
  Fluorine »
    PDB 7mmi-7n13 »
      7mx7 »

Fluorine in PDB 7mx7: PRMT5:MEP50 Complexed with Inhibitor Pf-06939999

Enzymatic activity of PRMT5:MEP50 Complexed with Inhibitor Pf-06939999

All present enzymatic activity of PRMT5:MEP50 Complexed with Inhibitor Pf-06939999:
2.1.1.320;

Protein crystallography data

The structure of PRMT5:MEP50 Complexed with Inhibitor Pf-06939999, PDB code: 7mx7 was solved by M.Mctigue, Y.L.Deng, W.Liu, A.Brooun, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 89.13 / 2.49
Space group I 2 2 2
Cell size a, b, c (Å), α, β, γ (°) 101.597, 137.477, 178.263, 90, 90, 90
R / Rfree (%) 22.2 / 27.9

Fluorine Binding Sites:

The binding sites of Fluorine atom in the PRMT5:MEP50 Complexed with Inhibitor Pf-06939999 (pdb code 7mx7). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total 3 binding sites of Fluorine where determined in the PRMT5:MEP50 Complexed with Inhibitor Pf-06939999, PDB code: 7mx7:
Jump to Fluorine binding site number: 1; 2; 3;

Fluorine binding site 1 out of 3 in 7mx7

Go back to Fluorine Binding Sites List in 7mx7
Fluorine binding site 1 out of 3 in the PRMT5:MEP50 Complexed with Inhibitor Pf-06939999


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of PRMT5:MEP50 Complexed with Inhibitor Pf-06939999 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F701

b:57.7
occ:1.00
F3 A:ZR1701 0.0 57.7 1.0
C16 A:ZR1701 1.3 57.2 1.0
C17 A:ZR1701 2.3 58.5 1.0
C15 A:ZR1701 2.4 55.4 1.0
F1 A:ZR1701 2.6 63.6 1.0
C21 A:ZR1701 2.8 54.2 1.0
C22 A:ZR1701 2.8 62.0 1.0
CB A:PHE327 2.9 62.9 1.0
OE2 A:GLU435 3.1 72.5 1.0
CG A:PHE327 3.1 63.6 1.0
CD2 A:PHE327 3.3 64.4 1.0
OH A:TYR334 3.4 68.9 1.0
CD A:GLU435 3.5 66.5 1.0
OE1 A:GLU435 3.5 64.6 1.0
NZ A:LYS333 3.5 76.2 1.0
C18 A:ZR1701 3.6 56.5 1.0
C14 A:ZR1701 3.6 54.9 1.0
CD1 A:PHE327 3.8 64.8 1.0
F2 A:ZR1701 4.1 63.6 1.0
C13 A:ZR1701 4.1 55.3 1.0
CA A:PHE327 4.2 63.1 1.0
CE2 A:PHE327 4.2 65.2 1.0
C20 A:ZR1701 4.3 53.6 1.0
O A:PHE327 4.3 65.2 1.0
C A:PHE327 4.5 64.9 1.0
CE1 A:PHE327 4.6 65.5 1.0
CZ A:TYR334 4.6 67.8 1.0
CG A:GLU435 4.7 59.8 1.0
CZ A:PHE327 4.8 65.2 1.0
CE A:LYS333 4.9 75.7 1.0
C19 A:ZR1701 4.9 53.9 1.0

Fluorine binding site 2 out of 3 in 7mx7

Go back to Fluorine Binding Sites List in 7mx7
Fluorine binding site 2 out of 3 in the PRMT5:MEP50 Complexed with Inhibitor Pf-06939999


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 2 of PRMT5:MEP50 Complexed with Inhibitor Pf-06939999 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F701

b:63.6
occ:1.00
F1 A:ZR1701 0.0 63.6 1.0
C22 A:ZR1701 1.4 62.0 1.0
F2 A:ZR1701 2.2 63.6 1.0
C17 A:ZR1701 2.4 58.5 1.0
F3 A:ZR1701 2.6 57.7 1.0
C16 A:ZR1701 2.9 57.2 1.0
OH A:TYR334 3.4 68.9 1.0
CB A:PHE327 3.5 62.9 1.0
CG A:PRO370 3.5 69.5 1.0
C18 A:ZR1701 3.6 56.5 1.0
CD2 A:PHE327 4.1 64.4 1.0
CD1 A:TYR324 4.1 49.4 1.0
CD A:PRO370 4.2 68.0 1.0
CG A:PHE327 4.2 63.6 1.0
C15 A:ZR1701 4.2 55.4 1.0
O A:TYR324 4.3 56.1 1.0
OE1 A:GLU435 4.3 64.6 1.0
OE2 A:GLU328 4.3 76.1 1.0
C A:PHE327 4.5 64.9 1.0
CG A:GLU328 4.6 70.4 1.0
O A:PHE327 4.6 65.2 1.0
N A:GLU328 4.6 65.8 1.0
CA A:PHE327 4.6 63.1 1.0
CZ A:TYR334 4.6 67.8 1.0
CA A:TYR324 4.7 54.3 1.0
C13 A:ZR1701 4.7 55.3 1.0
CB A:PRO370 4.8 69.0 1.0
CE1 A:TYR324 4.9 49.5 1.0
OE2 A:GLU435 4.9 72.5 1.0
CD A:GLU328 4.9 73.0 1.0
CD A:GLU435 5.0 66.5 1.0
CB A:TYR324 5.0 52.1 1.0
C A:TYR324 5.0 56.0 1.0

Fluorine binding site 3 out of 3 in 7mx7

Go back to Fluorine Binding Sites List in 7mx7
Fluorine binding site 3 out of 3 in the PRMT5:MEP50 Complexed with Inhibitor Pf-06939999


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 3 of PRMT5:MEP50 Complexed with Inhibitor Pf-06939999 within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F701

b:63.6
occ:1.00
F2 A:ZR1701 0.0 63.6 1.0
C22 A:ZR1701 1.4 62.0 1.0
F1 A:ZR1701 2.2 63.6 1.0
C17 A:ZR1701 2.4 58.5 1.0
C18 A:ZR1701 2.8 56.5 1.0
CA A:GLY367 3.2 59.4 1.0
CD1 A:TYR324 3.3 49.4 1.0
CE1 A:TYR324 3.6 49.5 1.0
C16 A:ZR1701 3.6 57.2 1.0
N A:GLY367 3.8 59.2 1.0
O A:ALA366 3.8 59.9 1.0
N A:ARG368 3.9 60.0 1.0
CD A:PRO370 3.9 68.0 1.0
C A:ALA366 4.0 59.6 1.0
C A:GLY367 4.0 60.0 1.0
F3 A:ZR1701 4.1 57.7 1.0
CG A:PRO370 4.1 69.5 1.0
C13 A:ZR1701 4.1 55.3 1.0
CG A:TYR324 4.4 50.0 1.0
OE2 A:GLU328 4.7 76.1 1.0
O2 A:ZR1701 4.7 52.1 1.0
C15 A:ZR1701 4.8 55.4 1.0
CZ A:TYR324 4.8 50.1 1.0
CB A:TYR324 4.9 52.1 1.0
OH A:TYR334 5.0 68.9 1.0
OE1 A:GLU435 5.0 64.6 1.0
C14 A:ZR1701 5.0 54.9 1.0

Reference:

K.Jensen-Pergakes, J.Tatlock, K.A.Maegley, I.J.Mcalpine, M.A.Mctigue, T.Xie, C.P.Dillon, Y.Wang, S.Yamazaki, N.Spiegel, M.Shi, A.Nemeth, N.Miller, E.Hendrickson, H.Lam, J.Sherrill, C.Y.Chung, E.A.Mcmillan, S.K.Bryant, P.Palde, J.Braganza, A.Brooun, Y.L.Deng, V.Goshtasbi, S.E.Kephart, R.A.Kumpf, W.Liu, R.L.Patman, E.Rui, S.Scales, M.Tran-Dube, F.Wang, M.Wythes, T.A.Paul. Sam Competitive PRMT5 Inhibitor Pf-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated Nsclc with Decreased Liability of Drug Resistance. Mol.Cancer Ther. 2021.
ISSN: ESSN 1538-8514
PubMed: 34737197
DOI: 10.1158/1535-7163.MCT-21-0620
Page generated: Tue Jul 15 21:54:40 2025

Last articles

Fe in 2YXO
Fe in 2YRS
Fe in 2YXC
Fe in 2YNM
Fe in 2YVJ
Fe in 2YP1
Fe in 2YU2
Fe in 2YU1
Fe in 2YQB
Fe in 2YOO
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy